Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1990 Oct;105(2):409–414. doi: 10.1017/s0950268800047981

Selective antenatal screening for toxoplasmosis and the latex agglutination test.

R E Holliman 1, K F Barker 1, J D Johnson 1
PMCID: PMC2271888  PMID: 2209743

Abstract

Recent publicity concerning congenital toxoplasmosis has generated a demand for serological assessment of pregnant women. Many laboratories are requested to undertake primary screening in these cases. We assessed the latex agglutination test (LAT) findings in 158 specimens with detectable toxoplasma specific IgM derived from pregnant women. The LAT titres ranged from 16 to greater than or equal to 4000 reflecting the variable antibody response observed in acute toxoplasmosis. We recommend that non-reference laboratories test specimens from pregnant women using the LAT at a screening dilution of 1:16 and select all reactive samples for detailed investigation.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araujo F. G., Remington J. S. Toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol. 1987 Feb;6(1):1–2. doi: 10.1007/BF02097180. [DOI] [PubMed] [Google Scholar]
  2. Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Aufrant C., Valenti D., Cox W. L. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988 Feb 4;318(5):271–275. doi: 10.1056/NEJM198802043180502. [DOI] [PubMed] [Google Scholar]
  3. Duffy K. T., Wharton P. J., Johnson J. D., New L., Holliman R. E. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol. 1989 Dec;42(12):1291–1295. doi: 10.1136/jcp.42.12.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ho-Yen D. O. Screening for congenital cytomegalovirus and toxoplasmosis. Lancet. 1989 Sep 30;2(8666):803–803. doi: 10.1016/s0140-6736(89)90865-9. [DOI] [PubMed] [Google Scholar]
  5. Holliman R. E., Johnson J., Duffy K., New L. Discrepant toxoplasma latex agglutination test results. J Clin Pathol. 1989 Feb;42(2):200–203. doi: 10.1136/jcp.42.2.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Huskinson J., Stepick-Biek P. N., Araujo F. G., Thulliez P., Suzuki Y., Remington J. S. Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J Clin Microbiol. 1989 Sep;27(9):2031–2038. doi: 10.1128/jcm.27.9.2031-2038.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson J., Duffy K., New L., Holliman R. E., Chessum B. S., Fleck D. G. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol. 1989 May;42(5):536–541. doi: 10.1136/jcp.42.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Joynson D. H., Payne R. Screening for toxoplasma in pregnancy. Lancet. 1988 Oct 1;2(8614):795–796. doi: 10.1016/s0140-6736(88)92443-9. [DOI] [PubMed] [Google Scholar]
  9. Kean B. H. Clinical Toxoplasmosis--50 years. Trans R Soc Trop Med Hyg. 1972;66(4):549–571. doi: 10.1016/0035-9203(72)90300-8. [DOI] [PubMed] [Google Scholar]
  10. Koppe J. G., Loewer-Sieger D. H., de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet. 1986 Feb 1;1(8475):254–256. doi: 10.1016/s0140-6736(86)90785-3. [DOI] [PubMed] [Google Scholar]
  11. Wreghitt T. G., Hakim M., Gray J. J., Balfour A. H., Stovin P. G., Stewart S., Scott J., English T. A., Wallwork J. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol. 1989 Feb;42(2):194–199. doi: 10.1136/jcp.42.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES